Date/Time: Tuesday, June 23, 2020 at 8 PM EST

 webinar will focus on best practices and multidisciplinary approaches in the management of hepatocellular carcinoma and the impact of the COVID-19 pandemic on treatment selection in patients with HCC.

Impact of the COVID pandemic on reentry and reopening

Selection of therapy during the pandemic, oral versus IV therapies and immunotherapy

Recent approval of atezolizumab + bevacizumab and how this will impact the treatment landscape of HCC

Associate Professor of Clinical Medicine; Medical Director of Clinical Investigations Support Office; Phase I program director, USC Norris Comprehensive Cancer Center, Los Angeles, CA

David Bruton Jr. Professor in Clinical Cancer Research; Associate Professor of Medicine; Medical Director of Liver Tumor Program; Clinical Chief of Hepatology, University of Texas Southwestern, Dallas, TX

Director of Gastroenterology, Transplant Hepatology, MD Anderson Cancer Center, La Jolla,CA

News

® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses. 

Gastrointestinal Cancer

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

COVID-19

COVID-19 condition center page is a comprehensive resource for clinical news and expert insights on how the COVID-19 pandemic has impacted multiple areas of oncology care and practice. This page features news articles, interviews in written and video format, and podcasts encompassing data of patients with COVID-19 and cancer, oncology drugs being tested against the virus, vaccine information for patients with cancer, and more. 

This Onclive® webinar will focus on best practices and multidisciplinary approaches in the management of hepatocellular carcinoma and the impact of the COVID-19 pandemic on treatment selection in patients with HCC. Join us Thursday, June 23, 2020 at 8 PM EST.

Exploring New Treatment Options In HCC